A study of compounds which inhibit vascular smooth muscle contraction.
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001464:Barium / Q000494:pharmacology; D001808:Blood Vessels / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006146:Guanidines / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D014700:Verapamil / Q000494:pharmacology
D006146:Guanidines; D001464:Barium; D011335:Proadifen; D014700:Verapamil; D010208:Papaverine; D011299:Prenylamine; D011188:Potassium; D009638:Norepinephrine; D010646:Phentolamine